Chi‐Kuan Chen

1.4k total citations
40 papers, 1.0k citations indexed

About

Chi‐Kuan Chen is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Chi‐Kuan Chen has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Surgery. Recurrent topics in Chi‐Kuan Chen's work include Cancer-related gene regulation (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Viral-associated cancers and disorders (3 papers). Chi‐Kuan Chen is often cited by papers focused on Cancer-related gene regulation (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Viral-associated cancers and disorders (3 papers). Chi‐Kuan Chen collaborates with scholars based in Taiwan, United States and Russia. Chi‐Kuan Chen's co-authors include An‐Shik Yang, Shih‐Wei Chen, Hsin‐Yi Lee, Yu‐Ching Chou, Her‐Young Su, Shin‐Ping Lin, Wen‐Chi Lin, Hung‐Cheng Lai, Mu‐Hsien Yu and Ya‐Wen Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Chemical Engineering Journal.

In The Last Decade

Chi‐Kuan Chen

39 papers receiving 995 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi‐Kuan Chen Taiwan 16 462 173 149 139 97 40 1.0k
Xiaoshuang Wang China 17 384 0.8× 157 0.9× 103 0.7× 118 0.8× 36 0.4× 40 1.0k
Rajeev Shrimali United States 15 397 0.9× 865 5.0× 114 0.8× 178 1.3× 84 0.9× 24 1.5k
Yao Tan China 14 359 0.8× 107 0.6× 195 1.3× 80 0.6× 25 0.3× 38 800
Vincent Yeung United States 18 497 1.1× 113 0.7× 184 1.2× 68 0.5× 26 0.3× 35 894
Huimin Hu China 17 385 0.8× 145 0.8× 69 0.5× 26 0.2× 40 0.4× 70 975
Ziying Lin China 21 545 1.2× 307 1.8× 307 2.1× 28 0.2× 184 1.9× 48 1.2k
Xiwen Sun China 15 252 0.5× 143 0.8× 148 1.0× 33 0.2× 26 0.3× 35 689
Hwee Tong Tan Singapore 18 639 1.4× 195 1.1× 166 1.1× 103 0.7× 15 0.2× 28 1.1k
Haitao Tao China 21 238 0.5× 557 3.2× 174 1.2× 69 0.5× 32 0.3× 61 974

Countries citing papers authored by Chi‐Kuan Chen

Since Specialization
Citations

This map shows the geographic impact of Chi‐Kuan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Kuan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Kuan Chen more than expected).

Fields of papers citing papers by Chi‐Kuan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Kuan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Kuan Chen. The network helps show where Chi‐Kuan Chen may publish in the future.

Co-authorship network of co-authors of Chi‐Kuan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Kuan Chen. A scholar is included among the top collaborators of Chi‐Kuan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Kuan Chen. Chi‐Kuan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chao, Wan‐Ru, et al.. (2020). The Her2 gene aberrations in mucinous ovarian carcinoma: Analysis of twenty-one cases. Taiwanese Journal of Obstetrics and Gynecology. 59(2). 346–347. 7 indexed citations
2.
Chang, Yuan‐Ching, Chi‐Kuan Chen, Ming‐Jen Chen, et al.. (2017). Expression of 3β-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status. Annals of Surgical Oncology. 24(13). 4033–4041. 16 indexed citations
3.
Chao, Wan‐Ru, et al.. (2016). Mutation-free expression of c-Kit proto-oncogene in primary adenocarcinoma of uterine cervix. Taiwanese Journal of Obstetrics and Gynecology. 55(5). 741–742. 1 indexed citations
4.
Tseng, Tsui‐Hwa, Ming‐Hsien Chien, Wea‐Lung Lin, et al.. (2016). Inhibition of MDA‐MB‐231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation‐mediated p21WAF1/CIP1expression. Environmental Toxicology. 32(2). 434–444. 111 indexed citations
5.
Chen, Chi‐Kuan, et al.. (2015). Castleman disease mimicking nodal recurrence of thyroid cancer. Endocrine. 51(2). 384–386. 5 indexed citations
6.
Wu, Yu‐Hung, Pa‐Fan Hsiao, & Chi‐Kuan Chen. (2015). Seborrheic Keratosis With Bowenoid Transformation. American Journal of Dermatopathology. 37(6). 462–468. 17 indexed citations
8.
Leu, Yi‐Shing, Jehn-Chuan Lee, Chung‐Ji Liu, et al.. (2014). EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy. OncoTargets and Therapy. 7. 2197–2197. 10 indexed citations
9.
Hua, Kuo‐Tai, Mingyang Wang, Min‐Wei Chen, et al.. (2014). The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis. Molecular Cancer. 13(1). 189–189. 130 indexed citations
10.
Chao, Wan‐Ru, Ming‐Yung Lee, Chi‐Kuan Chen, et al.. (2013). HER2 amplification and overexpression are significantly correlated in mucinous epithelial ovarian cancer. Human Pathology. 45(4). 810–816. 20 indexed citations
11.
Ho, Pei‐Yin, et al.. (2012). Incidentally discovered malignant mesothelioma of the tunica vaginalis. Journal of the Formosan Medical Association. 112(1). 57–58. 6 indexed citations
12.
Chen, Be‐Fong, et al.. (2010). Ovarian Borderline Mucinous Tumor With Stromal Microinvasion and Hemangiomatous Mural Nodules. International Journal of Gynecological Pathology. 29(3). 239–242. 7 indexed citations
13.
Chang, Sheng‐Tsung, et al.. (2010). Angioimmunoblastic T-cell Lymphoma of Cytotoxic T-cell Phenotype Containing a Large B-cell Proliferation With an Undersized B-cell Clonal Product. Applied immunohistochemistry & molecular morphology. 18(2). 185–189. 8 indexed citations
14.
Chang, Wen-Hsiung, et al.. (2010). Unusual presentation of desmoid tumor in the small intestine: a case report. Medical Oncology. 28(1). 159–162. 8 indexed citations
15.
Chang, Wen-Hsiung, et al.. (2009). Goblet Cell Carcinoid of the Jejunum. 25(1). 59–64. 1 indexed citations
16.
Chen, Chi‐Kuan. (2009). Biomarkers in Diagnostic Head and Neck Tumor Pathology. 25(2). 89–101. 1 indexed citations
17.
Su, Her‐Young, Hung‐Cheng Lai, Ya‐Wen Lin, et al.. (2009). Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway. International Journal of Cancer. 127(3). 555–567. 154 indexed citations
18.
Huang, Yu‐Chuen, Marcelo Chen, Yi‐Ming Shyr, et al.. (2008). Glycine N‐methyltransferase is a favorable prognostic marker for human cholangiocarcinoma. Journal of Gastroenterology and Hepatology. 23(9). 1384–1389. 16 indexed citations
19.
Hsieh, Chen-Hsi, Kuo‐Shyang Jeng, Ching‐Chung Lin, et al.. (2008). Combination of Sorafenib and Intensity Modulated Radiotherapy for Unresectable Hepatocellular Carcinoma. Clinical Drug Investigation. 29(1). 65–71. 36 indexed citations
20.
Li, Hsueh‐Yu, et al.. (2006). HIV infection initially presenting as sinonasal Burkitt's lymphoma. American Journal of Otolaryngology. 27(6). 433–435. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026